During the past decade, Ospedale, "Umberto I" conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale, "Umberto I"" #1 sponsor was "European Institute of Oncology" with 2 trials, followed by "Gruppo di Ricerca GISSI" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Deutsches Herzzentrum Muenchen" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale, "Umberto I"" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "Technical University of Munich" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale, "Umberto I"" are "Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients." (1 trials), "Atrial Fibrillation" (1 trials), "Bifascicular Block" (1 trials), "Colorectal Cancer" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Ospedale, "Umberto I"" in a lesser frequency.

Most popular intervention types in "Ospedale, "Umberto I"" are "Drug" (6 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "etoposide" (2 trials), "Conservative treatment group" (1 trials), "DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)" (1 trials) and "Interventional treatment group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale, "Umberto I"" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale, "Umberto I"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ospedale, "Umberto I", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale, "Umberto I", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".